HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrent hip arthroplasty dislocation: good outcome after cup augmentation in 20 patients followed for 2 years.

Abstract
Recurrent posterior dislocation occurs after primary total hip arthroplasty at rates of up to 7%. Component revision is regarded as standard management, but this major surgery may be unsuitable for elderly patients. We have developed a congruent polyethylene acetabular posterior lip augmentation device (PLAD) with a stainless steel backing plate. This can be used when there is no gross malalignment, wear or loosening of the primary components. We retrospectively compared 20 patients who had revision surgery with twenty patients who had been treated with the PLAD for recurrent posterior dislocation after primary Charnley total hip arthroplasty. In the PLAD group, the mean operative time, intraoperative blood loss, time spent in the high-dependency unit (HDU), transfusion requirements and the duration of hospital stay were all less than that in the revision group. There was no difference in the Oxford Hip Score between the groups at latest review 2 years after surgery. None of the patients in either group had suffered another dislocation.
AuthorsA Philip Charlwood, Neville W Thompson, Neill S Thompson, David E Beverland, James R Nixon
JournalActa orthopaedica Scandinavica (Acta Orthop Scand) Vol. 73 Issue 5 Pg. 502-5 (Oct 2002) ISSN: 0001-6470 [Print] England
PMID12440491 (Publication Type: Comparative Study, Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip (adverse effects)
  • Female
  • Follow-Up Studies
  • Hip Prosthesis
  • Humans
  • Joint Dislocations (diagnostic imaging, etiology, surgery)
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Prosthesis Design
  • Radiography
  • Recurrence
  • Reoperation
  • Retrospective Studies
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: